Yangzijiang Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd. signed the equity transfer contract to acquire Nanjing Xinguodu Technology Co., Ltd. from Shenzhen Xinguodu Technology Co. Ltd. (SZSE:300130) for CNY 53.3 million on June 27, 2016. Shenzhen Xinguodu Technology will no longer hold any stake in Nanjing Xinguodu Technology on completion of the transaction. Nanjing Xinguodu Technology reported total assets of CNY 1.82 billion, net assets of CNY 1.27 billion, revenues of CNY 977.57 million and operating profit of CNY 29.66 million as of December 31, 2015. The transaction has been approved by the Board of Directors and Board of supervisors of Shenzhen Xinguodu Technology and does not require shareholders’ approval. Yangzijiang Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd. cancelled the acquisition of Nanjing Xinguodu Technology Co., Ltd. from Shenzhen Xinguodu Technology Co. Ltd. (SZSE:300130) on June 27, 2017.